Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 201 results for "ranbaxy industries"

Withdraw nod for 28 drug applications of Ranbaxy: Sun Pharma to USFDA
Livemint.com

Sun Pharma unit asks US FDA to withdraw nod for 28 drug applic...

In a BSE filing, Sun Pharmaceutical Industries said: One of the company's wholly-owned subsidiaries has voluntarily requested the USFDA to withdraw approval for 28 Abbreviated New Drug Applications (ANDAs). It further said: These old Money Today, 1 month ago
[x]  

5 images for ranbaxy industries

Financial Express, 1 week ago
Uranium Investing News, 1 month ago
Financial Express, 3 months ago
Livemint.com, 4 months ago
The Freepress Journal, 5 months ago

Sun Pharma requests USFDA to withdraw 28 product approvals given to Ranbaxy

Drugmaker Sun Pharmaceutical Industries has voluntarily requested the United States Food and Drug Administration to withdraw approvals given to 28 Abbreviated New Drug Applications (ANDAs). These older drug products belong to erstwhile Ranbaxy Laboratories ...
 Business Line1 month ago
Uranium Investing News

Landmark Court Decision Upheld for Pharmaceutical Industry

, the courts upheld a favorable verdict for AstraZeneca and Ranbaxy, ruling that the companies did not violate antitrust laws several years ago with an alleged pay for delay deal. But these two drug makers aren't the only winners. The ruling is a ...
 Uranium Investing News1 month ago AstraZeneca, Ranbaxy prevail in landmark pay-for-delay case  FiercePharma1 month ago ASTRAZENECA : U.S. court upholds AstraZeneca, Ranbaxy win in Nexium antitrust trial  4 Traders1 month ago U.S. court upholds AstraZeneca, Ranbaxy win in Nexium antitrust ...  Investing.com1 month ago
[x]  

Finasteride Market: Industry Analysis Report, Regional Outlook, Application Development Potential & Forecast, 2016 2024.

"Finasteride market share comprises of Merck Sharp & Dohme, Sun Pharmaceuticals, Ranbaxy Laboratories, Dr. Reddys Laboratories and Intas Pharmaceuticals, Teva Pharmaceuticals, Actavis, Hetero Labs, Yabao Pharmaceuticals, Cipla, Yangtze River Pharma, ...
 Digital Journal1 month ago

Delhi HC tells Singh brothers to honour commitment to secure assets

NEW DELHI: Malvinder and Shivinder Singh, former promoters of Ranbaxy Laboratories, have a week to respond to the Delhi High Court on an application filed by Daiichi Sankyo, which is seeking to block the brothers from selling their assets. As ET ...
 Economic Times1 day ago Daiichi moves Delhi HC for restraining dilution of assets by Singh brothers  Livemint.com2 days ago
Sify

Top 22 stocks in focus today: Reliance Industries, Fortis Healthcare, Suzlon

India Infoline News Service | Mumbai | January 17, 2017 09:55 IST Check out the companies which will be in focus during trade today based on recent and latest news developments. Article saved successfully to my page. You must be Logged in to ...
 India Infoline2 days ago Sun Pharma: Down but not out  Smart Investor3 weeks ago SUN PHARMACEUTICAL INDUSTRIES : Pharma completes acquisition of 85.1% of Jio Biosintez, stocks down marginally  4 Traders4 weeks ago Sun Pharma Q2 profit more than doubles, beats estimates  Sify2 months ago
[x]  

Trump's comments on drug prices sink pharma stocks; Teva lowers guidance by $ 1 billion

View: 430 The New Year began with the JP Morgan Healthcare Conference— the drug industry's annual investor meet — where industry leaders were busy announcing deals, until Donald Trump accused the industry of getting away with murder. His ...
 PharmaCompass1 week ago
Financial Express

Morgan Stanley rates Sun Pharmaceutical Industries Equal-Weight

Sun continues to bolster its specialty pipeline—Tildrakizumab (Merck), Odomzo (Novartis), MM-II (Moebius), Seciera (Ocular), Elepsia/Xelpros (SPARC), BromSite/DexaSite (Insite), Absorica (Ranbaxy), and Dusa drug products. Sun announced that its ...
 Financial Express1 week ago
Livemint.com

What class action suit against Taro means for Sun Pharma

MUMBAI: Taro Pharmaceutical, the American unit of India's Sun Pharmaceutical Industries, is being sued by its investors for what they allege making false and misleading statements on fixing the price of generic drugs in violation of US antitrust ...
 Economic Times4 weeks ago SUN PHARMACEUTICAL INDUSTRIES : Pharma strong and healthy  4 Traders1 month ago ET 500: Sun Pharma strong and healthy  Economic Times1 month ago India Pharma Week 2016 debuts at CpHI & P-MEC India with Pre-Connect Congress  Express Pharma2 months ago
[x]  

Sun Pharma picks company veteran to tackle U.S. troubles

MUMBAI (NewsRise) -- Sun Pharmaceutical Industries has named company veteran and Chief Financial Officer Uday Baldota as the new chief executive of its U.S. unit, as India's largest drug maker braces for challenging times in its biggest market amid ...
 Nikkei Asian Review1 month ago Taro appoints Sun Pharma CFO Uday Baldota its CEO  Moneycontrol.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less